US4441441098 - Common Stock

We assign a fundamental rating of **6** out of 10 to **HDSN**. **HDSN** was compared to 52 industry peers in the **Trading Companies & Distributors** industry. **HDSN** gets an excellent profitability rating and is at the same time showing great financial health properties. **HDSN** has a bad growth rate and is valued cheaply. This makes **HDSN** very considerable for value investing!

In multiple years **HDSN** reported negative net income over the last 5 years.

Of the past 5 years **HDSN** 4 years had a positive operating cash flow.

With an excellent **Return On Assets** value of **15.74%**, **HDSN** belongs to the best of the industry, outperforming **96.15%** of the companies in the same industry.

The **Return On Equity** of **HDSN** (**19.41%**) is better than **65.38%** of its industry peers.

Looking at the **Return On Invested Capital**, with a value of **22.61%**, **HDSN** belongs to the top of the industry, outperforming **96.15%** of the companies in the same industry.

Measured over the past 3 years, the **Average Return On Invested Capital** for **HDSN** is significantly above the industry average of **11.00%**.

The 3 year average ROIC (**32.15%**) for **HDSN** is well above the current ROIC(**22.61%**). The reason for the recent decline needs to be investigated.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 15.74% | ||

ROE | 19.41% | ||

ROIC | 22.61% |

ROA(3y)23.56%

ROA(5y)10.62%

ROE(3y)42.58%

ROE(5y)11.5%

ROIC(3y)32.15%

ROIC(5y)N/A

With an excellent **Operating Margin** value of **24.65%**, **HDSN** belongs to the best of the industry, outperforming **80.77%** of the companies in the same industry.

In the last couple of years the **Operating Margin** of **HDSN** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 24.65% | ||

PM (TTM) | 16.71% | ||

GM | 37.02% |

OM growth 3Y89.14%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y17.17%

GM growth 5YN/A

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so **HDSN** is creating value.

The number of shares outstanding for **HDSN** has been increased compared to 1 year ago.

Compared to 5 years ago, **HDSN** has more shares outstanding

There is no outstanding debt for **HDSN**. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

An Altman-Z score of **6.59** indicates that **HDSN** is not in any danger for bankruptcy at the moment.

There is no outstanding debt for **HDSN**. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | 0 | ||

Altman-Z | 6.59 |

ROIC/WACC2.51

WACC9.01%

A Quick Ratio of **1.18** indicates that **HDSN** should not have too much problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 4.3 | ||

Quick Ratio | 1.18 |

Looking at the last year, **HDSN** shows a very negative growth in **Revenue**. The Revenue has decreased by **-11.12%** in the last year.

EPS 1Y (TTM)-44.22%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-51.22%

Revenue 1Y (TTM)-11.12%

Revenue growth 3Y25.11%

Revenue growth 5Y11.66%

Sales Q2Q%-16.79%

Based on estimates for the next years, **HDSN** will show a small growth in **Revenue**. The Revenue will grow by **4.19%** on average per year.

EPS Next Y-34.64%

EPS Next 2Y-5.56%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-8%

Revenue Next 2Y4.19%

Revenue Next 3YN/A

Revenue Next 5YN/A

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

94.23% of the companies in the same industry are more expensive than **HDSN**, based on the **Price/Earnings** ratio.

When comparing the **Price/Earnings** ratio of **HDSN** to the average of the S&P500 Index (**28.93**), we can say **HDSN** is valued rather cheaply.

Based on the **Price/Forward Earnings** ratio of **7.77**, the valuation of **HDSN** can be described as very cheap.

Compared to the rest of the industry, the **Price/Forward Earnings** ratio of **HDSN** indicates a rather cheap valuation: **HDSN** is cheaper than 86.54% of the companies listed in the same industry.

When comparing the **Price/Forward Earnings** ratio of **HDSN** to the average of the S&P500 Index (**20.52**), we can say **HDSN** is valued rather cheaply.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 9.8 | ||

Fwd PE | 7.77 |

Based on the **Enterprise Value to EBITDA** ratio, **HDSN** is valued cheaper than 96.15% of the companies in the same industry.

90.38% of the companies in the same industry are more expensive than **HDSN**, based on the **Price/Free Cash Flow** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 8.54 | ||

EV/EBITDA | 4.45 |

The excellent profitability rating of **HDSN** may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-5.56%

EPS Next 3YN/A

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**HUDSON TECHNOLOGIES INC**

NASDAQ:HDSN (8/13/2024, 7:11:23 PM)

After market: 8 -0.04 (-0.44%)**8.035**

**+0.57 (+7.56%) **

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryTrading Companies & Distributors

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap365.67M

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 9.8 | ||

Fwd PE | 7.77 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 15.74% | ||

ROE | 19.41% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 24.65% | ||

PM (TTM) | 16.71% | ||

GM | 37.02% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.94

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 4.3 | ||

Quick Ratio | 1.18 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-44.22%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y-34.64%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-11.12%

Revenue growth 3Y25.11%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y